40
Participants
Start Date
September 19, 2022
Primary Completion Date
April 26, 2024
Study Completion Date
April 26, 2024
Methylphenidate
0.35 mg/kg methylphenidate will be administered after baseline testing and 45 min-1 hr before post-intervention testing.
Placebo
Placebo for methylphenidate
Northwestern University, Chicago
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Northwestern University
OTHER